FDA: EMERGENCY AUTHORISATION OF THE BLOOD PLASMA TREATMENT

Highlights:

•          70,000 cases have already received convalescent blood treatment has been 

•          Trump approves of this move by the FDA    &n...

GILEAD SCIENCES WILL BE ABLE TO MEET THE GLOBAL REMDESIVIR DEMAND BY OCTOBER

Highlights

• By the year-end, it plans to produce more than 2 million treatment courses
• Since January, it has increased supply of the drug more than 50-fold

Gilead Sciences said on Thursday that it will be able to meet the global deman...

MERCK SCHEDULES PIVOTAL STUDY FOR ITS ORAL CORONA VIRUS TREATMENT IN SEPTEMBER

Highlights

• The experimental oral therapeutic is termed as MK-4482
• It is currently in phase two trials

Merck has scheduled very large pivotal studies as early as September. It is for its oral coronavirus treatment. It is in collaborat...

US BUYS THREE MONTHS WORTH OF REMDESIVIR, THE ANTI-VIRAL DRUG FOR COVID19 TREATMENT

Highlights: 

• Remdesivir is an anti-viral drug 
• It is solely produced by Gilead Sciences Inc.
• Was developed for Ebola treatment 

Gilead Science’s remdesivir, initially developed for treating Ebola, has shown immense pot...

IIBR (ISRAEL) DEVELOPS MONOCLONAL ANTI BODY TO FIGHT COVID19

Highlights:

• IIBR was tasked with finding a vaccine for covid19 by PM Benjamin Netanyahu
• This breakthrough treatment, if it works will be new hope for a covis19 free world

When the whole world is collaborating on research and findings for a vaccine an...